{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T21:26:47Z","timestamp":1794950807194,"version":"4.9.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jacbts.2026.101699","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:31:33Z","timestamp":1789680693000},"page":"101699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Novel Triglyceride- and Cholesterol-Enriched Lipoprotein(a) Phenotype in Moderate Hypertriglyceridemia"],"prefix":"10.1016","volume":"11","author":[{"given":"Lizhu","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiah N.","family":"Brush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Bradley","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica J.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip L.S.M.","family":"Gordts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9834-9494","authenticated-orcid":false,"given":"Sotirios","family":"Tsimikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacbts.2026.101699_bib1","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1194\/jlr.R061648","article-title":"Lipoprotein (a) measurements for clinical application","volume":"57","author":"Marcovina","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacbts.2026.101699_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.119218","article-title":"The brussels international declaration on lipoprotein(a) testing and management","volume":"406","author":"Kronenberg","year":"2025","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacbts.2026.101699_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jacc.2017.11.014","article-title":"Nhlbi working group recommendations to reduce lipoprotein(a)-mediated risk of cardiovascular disease and aortic stenosis","volume":"71","author":"Tsimikas","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2026.101699_bib4","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMp038128","article-title":"Lp(a) lipoprotein--coping with heterogeneity","volume":"349","author":"Scanu","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacbts.2026.101699_bib5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0005-2795(71)90223-6","article-title":"Purification and quantitation of the human plasma lipoprotein carrying the Lp(a) antigen","volume":"236","author":"Ehnholm","year":"1971","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jacbts.2026.101699_bib6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0021-9150(93)90117-D","article-title":"Plasma triglycerides and lipoprotein(a): inverse relationship in a hyperlipidemic Italian population","volume":"101","author":"Werba","year":"1993","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacbts.2026.101699_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0021-9150(94)90109-0","article-title":"Decreased plasma levels of lipoprotein(a) in patients with hypertriglyceridemia","volume":"108","author":"Bartens","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacbts.2026.101699_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2362.1995.tb01707.x","article-title":"Effect of hypertriglyceridaemia on lipoprotein (a) serum concentrations","volume":"25","author":"Walek","year":"1995","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jacbts.2026.101699_bib9","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.jacc.2009.02.041","volume":"53","author":"Fraley","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2026.101699_bib10","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1016\/S0021-9258(18)32663-2","article-title":"Human plasma lipoprotein [a]. Structural properties","volume":"258","author":"Gaubatz","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacbts.2026.101699_bib11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0005-2760(97)00049-0","article-title":"Association of Lp(a) rather than integrally-bound apo(a) with triglyceride-rich lipoproteins of human subjects","volume":"1346","author":"Marcoux","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jacbts.2026.101699_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0021-9150(92)90247-E","article-title":"Correlation of apolipoprotein(a) isoproteins with Lp(a) density and distribution in fasting plasma","volume":"94","author":"Reblin","year":"1992","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacbts.2026.101699_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2026.100996","article-title":"A novel immune-isolation method for direct quantification of triglycerides associated with lipoprotein(a)","volume":"67","author":"Lin","year":"2026","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacbts.2026.101699_bib14","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1172\/JCI86610","article-title":"Apoc-iii inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors","volume":"126","author":"Gordts","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacbts.2026.101699_bib15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/MOL.0000000000000502","article-title":"Apolipoprotein c-iii in triglyceride-rich lipoprotein metabolism","volume":"29","author":"Ramms","year":"2018","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacbts.2026.101699_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100475","article-title":"Apolipoprotein C3: form begets function","volume":"65","author":"Bornfeldt","year":"2024","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacbts.2026.101699_bib17","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/S0022-2275(20)37140-6","article-title":"Cellular uptake of lipoprotein[a] by mouse embryonic fibroblasts via the LDL receptor and the LDL receptor-related protein","volume":"38","author":"Reblin","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacbts.2026.101699_bib18","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1093\/eurheartj\/ehz209","article-title":"N-acetyl galactosamine-conjugated antisense drug to apoc3 mRNA, triglycerides and atherogenic lipoprotein levels","volume":"40","author":"Alexander","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2026.101699_bib19","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/eurheartj\/ehab820","article-title":"Apolipoprotein c-iii reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk","volume":"43","author":"Tardif","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2026.101699_bib20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11883-025-01345-4","article-title":"Anti-apoc-iii therapies and implications for treatment of pancreatitis and cardiovascular disease","volume":"27","author":"Tsimikas","year":"2025","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacbts.2026.101699_bib21","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa2400201","article-title":"Olezarsen, acute pancreatitis, and familial chylomicronemia syndrome","volume":"390","author":"Stroes","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacbts.2026.101699_bib22","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa2507227","article-title":"Targeting apoc3 with olezarsen in moderate hypertriglyceridemia","volume":"393","author":"Bergmark","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacbts.2026.101699_bib23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJMoa2512761","article-title":"Olezarsen for managing severe hypertriglyceridemia and pancreatitis risk","volume":"394","author":"Marston","year":"2026","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacbts.2026.101699_bib24","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1161\/01.CIR.0000130844.01174.55","article-title":"Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein","volume":"109","author":"Tsimikas","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2026.101699_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100053","article-title":"Novel method for quantification of lipoprotein(a)-cholesterol: implications for improving accuracy of LDL-c measurements","volume":"62","author":"Yeang","year":"2021","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacbts.2026.101699_bib26","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jacc.2021.12.032","article-title":"Effect of pelacarsen on lipoprotein(a) cholesterol and corrected low-density lipoprotein cholesterol","volume":"79","author":"Yeang","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2026.101699_bib27","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/clinchem\/32.8.1484","article-title":"Two new monoclonal antibody-based enzyme-linked assays of apolipoprotein B","volume":"32","author":"Young","year":"1986","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacbts.2026.101699_bib28","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/01.ATV.6.2.178","article-title":"Conservation of the low density lipoprotein receptor-binding domain of apoprotein b. Demonstration by a new monoclonal antibody, mb47","volume":"6","author":"Young","year":"1986","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.jacbts.2026.101699_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2026.100976","article-title":"Analytical validation of monoclonal antibody-based elisa methods for OxPL-apoB and OxPL-apo(a)","volume":"67","author":"Marcovina","year":"2026","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacbts.2026.101699_bib30","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1194\/jlr.P027235","article-title":"Acute impact of apheresis on oxidized phospholipids in patients with familial hypercholesterolemia","volume":"53","author":"Arai","year":"2012","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacbts.2026.101699_bib31","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/ATVBAHA.117.309007","article-title":"Apolipoprotein c-iii levels and incident coronary artery disease risk: the epic-norfolk prospective population study","volume":"37","author":"van Capelleveen","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacbts.2026.101699_bib32","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1172\/JCI112345","article-title":"Fat feeding in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein [a] and that cause lipid accumulation in macrophages","volume":"77","author":"Bersot","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacbts.2026.101699_bib33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0009-3084(94)90138-4","article-title":"Post-prandial Lp(a): identification of a triglyceride-rich particle containing apo e","volume":"67-68","author":"Scanu","year":"1994","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.jacbts.2026.101699_bib34","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/S0022-2275(20)31535-2","article-title":"Isolation, quantitation, and characterization of a stable complex formed by lp[a] binding to triglyceride-rich lipoproteins","volume":"42","author":"Gaubatz","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacbts.2026.101699_bib35","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0022-2275(20)42790-7","article-title":"Solubility, immunochemical, and lipoprotein binding properties of apoB-100-apo[a], the protein moiety of lipoprotein[a]","volume":"31","author":"Fless","year":"1990","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacbts.2026.101699_bib36","doi-asserted-by":"crossref","first-page":"11470","DOI":"10.1016\/S0021-9258(18)90885-9","article-title":"Heterogeneity of human plasma lipoprotein (a). Isolation and characterization of the lipoprotein subspecies and their apoproteins","volume":"259","author":"Fless","year":"1984","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacbts.2026.101699_bib37","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0022-2275(20)38320-6","article-title":"Enzyme-linked immunoassay for lp[a]","volume":"30","author":"Fless","year":"1989","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacbts.2026.101699_bib38","doi-asserted-by":"crossref","first-page":"13492","DOI":"10.1021\/bi00249a038","article-title":"Subunit composition of lipoprotein(a) protein","volume":"33","author":"Fless","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.jacbts.2026.101699_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.119166","article-title":"Genetically determined increase in apolipoprotein c-iii (apoc3 gain-of-function) delays very low-density lipoprotein clearance in humans","volume":"404","author":"Packard","year":"2025","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacbts.2026.101699_bib40","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/joim.13059","article-title":"Contribution of remnant cholesterol to cardiovascular risk","volume":"288","author":"Langsted","year":"2020","journal-title":"J Intern Med"},{"key":"10.1016\/j.jacbts.2026.101699_bib41","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: Metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2026.101699_bib42","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jacl.2022.06.005","article-title":"Effect of olezarsen targeting APOC-III on lipoprotein size and particle number measured by nmr in patients with hypertriglyceridemia","volume":"16","author":"Karwatowska-Prokopczuk","year":"2022","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacbts.2026.101699_bib43","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.jacc.2025.03.496","article-title":"Effect of targeting apoc-iii with plozasiran on lipoprotein particle size and number in hypertriglyceridemia","volume":"85","author":"Ballantyne","year":"2025","journal-title":"J Am Coll Cardiol"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X26002226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X26002226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T21:05:08Z","timestamp":1794949508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X26002226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2452302X26002226"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2026.101699","relation":{},"ISSN":["2452-302X"],"issn-type":[{"value":"2452-302X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Novel Triglyceride- and Cholesterol-Enriched Lipoprotein(a) Phenotype in Moderate Hypertriglyceridemia","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2026.101699","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"101699"}}